| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $3.04B | +36.8% |
| Cost of Revenue | $1.94B | +21.5% |
| Gross Profit | $1.11B | +75.2% |
| R&D Expense | $28.7M | +27.5% |
| SG&A Expense | $434.3M | +28.7% |
| Operating Income | $646.2M | +136.7% |
| Interest Expense | $25.3M | -1.2% |
| Pre-tax Income | $621.0M | +117.9% |
| Income Tax | $147.7M | +2328.9% |
| Net Income | $473.2M | +77.9% |
| EPS (Basic) | $8.27 | +81.0% |
| EPS (Diluted) | $8.00 | +80.2% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.6M | -90.7% |
| Accounts Receivable | $356.8M | +18.3% |
| Inventory | $643.0M | +41.5% |
| Current Assets | $1.11B | +4.4% |
| Total Assets | $2.40B | +35.8% |
| Current Liabilities | $393.9M | +6.2% |
| Long-term Debt | $666.1M | +34.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $318.3M | -7.8% |
| Capital Expenditures | $42.8M | +41.8% |
| Investing Cash Flow | -$587.8M | -476.2% |
| Financing Cash Flow | $49.0M | +254.8% |
| Free Cash Flow | $275.5M | -12.6% |
| Total Liabilities |
| $1.27B |
| +23.7% |
| Stockholders' Equity | $1.12B | +52.6% |